Edna Cukierman Elected to Council of the American Society for Matrix Biology

January 23, 2020

PHILADELPHIA (January 23, 2020) – Edna (Eti) Cukierman, PhD, an associate professor in the Cancer Biology program at Fox Chase Cancer Center, has been elected to the council of the American Society for Matrix Biology (ASMB). The mission of the organization is to promote basic, translational, and clinical research on the extracellular matrix, the noncellular portion of tissue that provides structural and biochemical support to surrounding cells.

“I’m greatly honored to be elected to the council by my colleagues,” said Cukierman, who is also co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute at Fox Chase. “I would like to use this opportunity to broaden ASMB membership and our outreach to the scientific community.”

Her research in extracellular matrix biology began with a postdoctoral fellowship from 1997 through 2002 at the National Institute of Dental and Craniofacial Research at the National Institutes of Health. It was during this time that a system she developed rendered, for the first time, a multilayered fibroblastic cell-derived extracellular matrix (CDM). Today, CDMs are broadly used in research.

Cukierman came to Fox Chase in 2002 and has been funded by the National Cancer Institute continuously since 2004. Early in her career, she received a long-running Career Development Award from the American Association for Cancer Research and has also received the National Pancreas Foundation Award.

She served as a long-standing member of the American Cancer Society, with a focus on postdoctoral and young investigator awards. She is an active member of various professional organizations and serves as scientific editor of several journals, including Matrix Biology.

Born and raised in Mexico City, Cukierman immigrated to Israel in 1986 and earned her doctoral degree from the Technion-Israel Institute of Technology in 1997.  

Cukierman said she is eager to share her teaching, mentoring, and professional sponsoring philosophy of “leading by example” as a Latina woman in science, technology, engineering, and mathematics (STEM) with young trainees and established peers alike.

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.


For more information, call 888-369-2427

Connect with Fox Chase